Long-term experience with Sandimmun Neoral: Results in De novo and stable renal transplant patients after 24-month treatment

Transplantation Proceedings

Volumn 29, Issue 7, 1997, Pages 2945-2947

  Korn, A ^a   Farber L ^b   Maibucher A ^b   Buchholz, B ^b   Offermann, G ^b  

^a Klinische Forschung   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; CONFERENCE PAPER; DRUG ABSORPTION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CREATININE; CYCLOSPORINE; DOSAGE FORMS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GERMANY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TIME FACTORS;

EID: 0030859749     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(97)00739-2     Document Type: Conference Paper

References (6)

1. Meinzer A, Vorderscher J: To Life 4:12, 1993
2. Mueller EA, et al: Pharm Res 11:301, 1994
3. Kovarik JM, et al: Ther Drug Monit 16:232, 1994
4. Kovarik JM, et al: Transplantation 58:658, 1994
5. Holt DW, et al: Transplant Proc 27:1434, 1995
6. Lindholm A, Kahan BD: Clin Pharmacol Ther 54:205, 1993